Sign inGet started

ZDRAVESKI ZORAN

Insider CIK 1741285 · MGTA See Remarks · TCRX See Remarks

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TCRX TScan Therapeutics, Inc. A Award2026-10-012026-10-02300,000— $0304,716SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2026-01-202026-01-22350,000— $0350,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2025-01-032025-02-11250,000— $0250,000SEC↗
TCRX TScan Therapeutics, Inc. M Exercise deriv2024-08-232024-08-2713,125— $021,875SEC↗
TCRX TScan Therapeutics, Inc. M Exercise deriv2024-08-232024-08-2754,895— $030,105SEC↗
TCRX TScan Therapeutics, Inc. M Exercise deriv2024-08-232024-08-2725,000— $025,000SEC↗
TCRX TScan Therapeutics, Inc. M Exercise deriv2024-08-232024-08-2764,166— $0365,834SEC↗
TCRX TScan Therapeutics, Inc. M Exercise2024-08-232024-08-2754,895$4.85 $266.2K67,111SEC↗
TCRX TScan Therapeutics, Inc. M Exercise2024-08-232024-08-2725,000$3.27 $81.8K92,111SEC↗
TCRX TScan Therapeutics, Inc. M Exercise2024-08-232024-08-2713,125$1.81 $23.8K105,236SEC↗
TCRX TScan Therapeutics, Inc. M Exercise2024-08-232024-08-2764,166$2.49 $159.8K169,402SEC↗
TCRX TScan Therapeutics, Inc. S Sale2024-08-232024-08-27164,686$5.78 $951.9K4,716SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2024-01-122025-02-1152,500— $052,500SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2023-06-132023-06-15430,000— $0430,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2023-02-022023-02-0635,000— $035,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2022-07-252022-07-2750,000— $050,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2022-01-182022-01-2085,000— $085,000SEC↗
TCRX TScan Therapeutics, Inc. P Buy2021-09-232021-09-274,716$7.48 $35.3K4,716SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2021-09-072021-09-09150,000— $0150,000SEC↗
MGTA Magenta Therapeutics, Inc. A Award deriv2021-02-112021-02-1667,700— $067,700SEC↗
MGTA Magenta Therapeutics, Inc. A Award deriv2020-02-102020-02-1260,000— $060,000SEC↗
MGTA Magenta Therapeutics, Inc. M Exercise deriv2019-12-242019-12-30820— $016,856SEC↗
MGTA Magenta Therapeutics, Inc. S Sale2019-12-242019-12-267,902$16.00 $126.4K128,009SEC↗
MGTA Magenta Therapeutics, Inc. M Exercise2019-12-242019-12-30820$7.71 $6.3K140,912SEC↗
MGTA Magenta Therapeutics, Inc. S Sale2019-12-242019-12-307,902$16.00 $126.4K133,010SEC↗
MGTA Magenta Therapeutics, Inc. M Exercise deriv2019-12-232019-12-309— $017,676SEC↗
MGTA Magenta Therapeutics, Inc. M Exercise deriv2019-12-232019-12-304,172— $0129,342SEC↗
MGTA Magenta Therapeutics, Inc. S Sale2019-12-232019-12-264,181$16.03 $67.0K135,911SEC↗
MGTA Magenta Therapeutics, Inc. S Sale2019-12-232019-12-304,181$16.03 $67.0K140,092SEC↗
MGTA Magenta Therapeutics, Inc. M Exercise2019-12-232019-12-304,172$9.49 $39.6K144,273SEC↗
MGTA Magenta Therapeutics, Inc. M Exercise2019-12-232019-12-309$7.71 $69140,101SEC↗
MGTA Magenta Therapeutics, Inc. A Award deriv2019-02-052019-02-0780,000— $080,000SEC↗
MGTA Magenta Therapeutics, Inc. C Conversion deriv2018-06-252018-06-2712,000— $00SEC↗
MGTA Magenta Therapeutics, Inc. C Conversion2018-06-252018-06-274,643— $0140,092SEC↗